Halozyme Therapeutics Inc. Common Stock vs Mitsubishi UFJ Financial Group Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Mitsubishi UFJ Financial Group Inc. Common Stock trades at $22.38 (market cap $249.48B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 19.8× Halozyme Therapeutics Inc. Common Stock's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.4% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Mitsubishi UFJ Financial Group Inc. Common Stock for 0 Days on average.
| HALO | MUFG | |
|---|---|---|
Market Cap | $12.58B | $249.48B |
Volume | 2,179,278 | 4,008,160 |
Sector | Health | Financials |
52-Week High | $115.22 | $24.13 |
52-Week Low | $61.63 | $14.62 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $14.49B | $28.96T |
Dividend Yield | — | 2.4% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.
Read more on MUFG →